Alexandra MacLean

Alexandra MacLean is recorded as Board Member at Avenue Therapeutics, Inc. (ATXI) since January 1, 2023 and CEO at Avenue Therapeutics, Inc. (ATXI). The newest filing on record that lists Alexandra MacLean as CEO and Board Member at Avenue Therapeutics, Inc. (ATXI) is dated December 5, 2025. The proxy statement of Avenue Therapeutics, Inc. reports total compensation of $280,542 for Alexandra MacLean in fiscal 2022, including a base salary of $153,585. Disclosed compensation is on record for 2 fiscal years. Avenue Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avenue Therapeutics, Inc. includes Alexandra MacLean, M.D. (CEO and Board Member), Jay Kranzler, M.D., Ph.D. (Chairman and Board Member), David Jin (CFO) and 7 others.